Chemotherapy for Stomach Cancer

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1987 Oct 10

PMID 3119080

Citations 1

Authors

P I Clark

M L Slevin

Affiliations

Soon will be listed here.

Citing Articles

Identification of a chemotherapy-associated gene signature for a risk model of prognosis in gastric adenocarcinoma through bioinformatics analysis.

Shen Y, Chen K, Gu C J Gastrointest Oncol. 2022; 13(5):2219-2233.

PMID: 36388651 PMC: 9660031. DOI: 10.21037/jgo-22-872.

References

Fujimoto S, Akao T, Itoh B, Koshizuka I, Koyano K . Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Ann Surg. 1977; 185(4):462-6. PMC: 1396135. DOI: 10.1097/00000658-197704000-00016. View

LUNDH G, BURN J, KOLIG G, Richard C, Thomson J, van Elk P . A co-operative international study of gastric cancer (under the auspices of the International Federation of Surgical Colleges). Ann R Coll Surg Engl. 1974; 54(5):219-28. PMC: 2388384. View

Kingston R, Ellis D, Powell J, BROOKES V, Waterhouse J, Hurst M . The West Midlands gastric carcinoma chemotherapy trial: planning and results. Clin Oncol. 1978; 4(1):55-69. View

Nakajima T, Fukami A, Ohashi I, Kajitani T . Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int J Clin Pharmacol Biopharm. 1978; 16(5):209-16. View

MOERTEL C, Engstrom P, Lavin P, Gelber R, Carbone P . Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". Surgery. 1979; 85(5):509-13. View

Rake M, Mallinson C, Cocking J, Cwynarski M, Fox C, Wass V . Chemotherapy in advanced gastric cancer: a controlled, prospective, randomised multi-centre study. Gut. 1979; 20(9):797-801. PMC: 1412657. DOI: 10.1136/gut.20.9.797. View

FIELDING J, Fagg S, Jones B, Ellis D, Hockey M, Minawa A . An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World J Surg. 1983; 7(3):390-9. DOI: 10.1007/BF01658089. View

ANDERSON J, Cain K, Gelber R . Analysis of survival by tumor response. J Clin Oncol. 1983; 1(11):710-9. DOI: 10.1200/JCO.1983.1.11.710. View

Nakajima T, Takahashi T, Takagi K, Kuno K, Kajitani T . Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol. 1984; 2(12):1366-71. DOI: 10.1200/JCO.1984.2.12.1366. View

10.

Douglass Jr H, Lavin P, GOUDSMIT A, Klaassen D, Paul A . An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). J Clin Oncol. 1984; 2(12):1372-81. DOI: 10.1200/JCO.1984.2.12.1372. View

11.

Cullinan S, MOERTEL C, Fleming T, Rubin J, Krook J, Everson L . A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA. 1985; 253(14):2061-7. View

12.

Engstrom P, Lavin P, Douglass Jr H, BRUNNER K . Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer. 1985; 55(9):1868-73. DOI: 10.1002/1097-0142(19850501)55:9<1868::aid-cncr2820550904>3.0.co;2-b. View

13.

Cullinan S, MOERTEL C . FAM therapy for advanced gastric cancer: an ideal standard?. J Clin Oncol. 1985; 3(6):887-9. DOI: 10.1200/JCO.1985.3.6.887. View

14.

Oconnell M . Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol. 1985; 3(7):1032-9. DOI: 10.1200/JCO.1985.3.7.1032. View

15.

Schein P . The role of chemotherapy in the management of gastric and pancreatic carcinomas. Semin Oncol. 1985; 12(4 Suppl 6):49-60. View

16.

De Lisi V, COCCONI G, Tonato M, Di Costanzo F, Leonardi F, Soldani M . Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC). Cancer Treat Rep. 1986; 70(4):481-5. View

17.

LEVI J, Fox R, Tattersall M, Woods R, Thomson D, Gill G . Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. J Clin Oncol. 1986; 4(9):1348-55. DOI: 10.1200/JCO.1986.4.9.1348. View

18.

Howson C, Hiyama T, Wynder E . The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986; 8:1-27. DOI: 10.1093/oxfordjournals.epirev.a036288. View

19.

DIXON W, LONGMIRE Jr W, HOLDEN W . Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma: ten-year follow-up. Ann Surg. 1971; 173(1):26-39. PMC: 1397139. DOI: 10.1097/00000658-197101000-00004. View

20.

Imanaga H, Nakazato H . Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg. 1977; 2(1):213-21. DOI: 10.1007/BF01665086. View